Sitara Peroxide Limited
PPSX:SPL47.95
PKR
-0.99
(-2.02%)
Sitara Peroxide Limited
PSX:SPL
(Pakistan Stock Exchange)
Recent
price
47.95
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Sitara Peroxide Limited is a Pakistan-based chemical manufacturing enterprise primarily engaged in the industrial production, marketing, and distribution of hydrogen peroxide and specialized chemical formulations. Founded in 2004 and headquartered in Faisalabad, Pakistan, with its registered corporate office situated in Karachi, the company operates as a key subsidiary business within the industrial conglomerate Sitara Group. Sitara Peroxide Limited manufactures and supplies a comprehensive portfolio of industrial chemical solutions, including Hydrogen Peroxide (H2O2) formulated in standard and high concentrations such as 35% and 50% technical grades; Sitara Safe branded commercial disinfectant and sanitizing formulations; and tailored oxidation compounds. The company delivers its chemical products through specialized logistics formats comprising high-density polyethylene carboys and cans; intermediate bulk containers (IBCs); heavy-duty polymer drums; and dedicated fleet transport utilizing grade-316 stainless steel road tankers. Its product lines serve critical industrial operations across numerous sectors, including textile bleaching, scouring, and dye preparation; pulp and paper delignification and de-inking; aseptic packaging and beverage container sterilization; organic and inorganic chemical synthesis; municipal and industrial wastewater effluent oxidation; printed circuit board (PCB) micro-etching in electronics; and metallurgical extraction processes. In recent developments, Sitara Peroxide Limited initiated a strategic operational transition, placing its manufacturing plant under an extensive Balancing, Modernization, and Replacement (BMR) program to upgrade production efficiency, integrate modern process technology, and mitigate past energy supply and operational headwinds. Complementing this operational restructuring, the company successfully executed a full and final debt settlement with its primary financing creditor, UBL Sukuk, and entered into structured settlement and debt-restructuring negotiations with other institutional lenders to rationalize its balance sheet. To facilitate the completion of the BMR upgrades and support the resumption of commercial manufacturing, management is actively pursuing recapitalization initiatives through fresh equity injections, debt financing arrangements, and technical collaborations with international engineering and technology providers.